Galleri® Multi-Cancer Early Detection Test

Description

Detect cancer before it advances. The Galleri® test is an advanced, clinically validated blood test that screens for a broad range of aggressive cancers—often before symptoms appear. Using cutting-edge methylation technology, Galleri® analyzes DNA fragments in the bloodstream to identify a Cancer Signal, and when present, predicts the Cancer Signal Origin (CSO) to guide diagnostic follow-up. With just one test, you and your physician gain powerful insights that can support earlier detection, more informed decisions, and potentially better outcomes. Because when it comes to cancer, earlier is everything.